Assistant Professor of Neurology
Harvard Medical School/Mass General Brigham Health/Harvard Vanguard Medical Associates
Harvard Medical School
Braintree, Massachusetts
Paul G. Mathew, MD, DNBPAS, FAAN, FAHS completed his neurology residency at Temple University Hospital in Philadelphia, PA, and a fellowship in headache medicine at Mayo Clinic in Rochester, MN. He is board certified in neurology and headache medicine. He is an Assistant Professor of Neurology at Harvard Medical School (HMS), and an Affiliate Member of the HMS Division of Sleep Medicine. He has clinical appointments at Mass General Brigham and Harvard Vanguard Medical Associates/Atrius Health.
He has written over 90 publications, and has presented at both national and international conferences. He is the Co-Chief Medical Editor of the journal Practical Neurology. He is the current Chair of the American Headache Society’s Trigeminal Autonomic Cephalgia Special Interest Section, Vice-Chair of the Headache and Facial Pain Section of the America Academy of Neurology, a Member of the Board of the Directors of the National Headache Foundation, and an Executive Board Member of the Indian Medical Association of New England.
In March, 2015, Dr. Mathew was appointed as the neurology representative on the advisory board of the National Board of Physicians and Surgeons (www.NBPAS.org). The National Board of Physicians and Surgeons is an organization committed to providing board re-certification that ensures physician compliance with national standards and lifelong learning after completing initial board certification with a member board of the American Board of Medical Specialties (ABMS) or the American Osteopathic Association (AOA).
His advocacy work also includes diversity, equity, and inclusion (DEI) efforts in the domains of race, ethnicity, gender, and age. Since 2020, he has served on the Diversity Committee of the New England Chapter of the American College of Sports Medicine. Through his leadership positions within Practical Neurology, AAN, AHS, NHF, and NBPAS, he has lobbied for underrepresented groups in medicine to have greater leadership, speaking, authorship, and editorial opportunities.
Relevant Relationships Disclosed to Learners:
Consulting Fee (e.g., Advisory Board): Abbvie/Allergan, Amgen, Biohaven, Impel, Lilly, Theranica, Satsuma, Upsher-Smith
Wednesday, September 7, 2022
3:40 PM – 4:30 PM
Thursday, September 8, 2022
4:40 PM – 5:30 PM